What does the future hold for CIRM? I asked former CIRM Board Chair and Prop 71 leader, Robert Klein, about that and more in the interview below. He also says some particularly exciting clinical trial and other developments in the stem cell field are coming soon. What got you excited for the very first time […]
Interview with Robert Klein on CIRM’s Future Read More »
Where do things stand with some players in the for-profit world of stem cell and cellular medicine companies? Here are a few brief news items with quick analysis. Mesoblast is dominating the news of late. Mesoblast reported good news from its Phase II safety trial for its mesenchymal progenitor cell (MPC) product in patients with
Stem Cell & Cell Med Industry Briefs Read More »
What would your predictions be for 7 years down the road and by the way please read the eye chart below out loud. How’s your vision? Today’s post is a chance to let one’s optimism and excitement about stem cells run a bit wild looking ahead not to next year, but 7 years ahead to
20/20 Stem Cell Predictions for the Year 2020 Read More »
Dr. Joanne Kurtzberg is a stem cell pioneer and has advanced the development of innovative stem cell therapies including those based on umbilical cord blood. She is a faculty member at Duke where she conducts her clinical research. I recently interviewed Dr. Kurtzberg and below is Part 1 of 2 of the interview. Part 2,
Stem Cell Pioneer Joanne Kurtzberg interview, Part 1 Read More »
This is a guest post on ISSCR 2013. By Dr. Susan Lim A record 4100 delegates attended the 11th Annual Meeting of the International Society for Stem Cell Research (ISSCR), held at the Convention and Exhibition Center in Boston from 12-15 June 2013. Co-sponsored by the Harvard Stem Cell Institute, the Meeting featured 7 Plenary
Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim Read More »
Today’s post is an interview I did with Dr. Van Bokkelen covering 10 questions. Dr. Gil Van Bokkelen is Chairman and CEO of Athersys, Inc., a company that has focused heavily on stem cells and regenerative medicine for more than a decade. For more on Dr. Van Bokkelen’s background see additional bio section at the end of
Interview with Gil Van Bokkelen of Athersys Read More »
I finally got a chance to read the Cell paper by the Melton team on Betatrophin and it is quite cool. Update — Unfortunately the Betatrophin paper discussed here originally back in 2013 has now largely been proven to have come to incorrect conclusions (for more read this). I think one big question is whether
More on Betatrophin, my take on the Cell paper, and a video Read More »
Harvard Stem Cell Institute (HSCI) is making a big announcement today about stems, the biggest they say in their almost decade-long existence. Last night I speculated/predicted some possible announcements. Today I’m betting they will announce the discovery of a novel factor called Betatrophin. More on Betatrophin in a minute, but first why do I think
What is Betatrophin & why is Harvard so excited about it? Read More »
Clinicaltrials.gov is where you want to go for finding a certain clinical trial and studies. Note that this U.S. database Clinicaltrials.gov includes international trials. It is a very powerful tool! Check it out here to do your own searches. Also follow me on Twitter for all the latest info and expert analysis: http://twitter.com/pknoepfler and this patient’s
Tool to easily search for a stem cell clinical trial for your disease Read More »
The upcoming movie The Amazing Spider-Man with Emma Stone looks to be pretty cool and I’m not even a fan of Spider-Man. However, making me even more interested in it are the rumors that stem cells are part of the plot. Some folks view stem cells as superheroes able to cure almost anything including COVID-19, but
Emma Stone dishes on spiderman and stem cells: very cool! Read More »